In summary: to find out if a cosmetic contains ingredients identified as potential endocrine disruptors, read the list of ingredients (INCI) on the packaging and look for the names in the table in this guide. A prohibited ingredient is not the same as a restricted or evaluated one: prohibited ingredients cannot be in any legal cosmetic in the EU, and restricted ones are only allowed in certain products and below a limit. At Banbu, we also exclude ingredients that are still legal but are being evaluated.
Endocrine disruptors (EDCs) are substances that can alter the functioning of the hormonal system. The scientific community and European authorities are studying their possible health effects, and regulations are updated as new evaluations emerge.
In this context, many people ask us:
Does Banbu only exclude the substances on the EU priority list, or do you go further? Do you rely solely on SCCS evaluations? Does this mean that current cosmetics are unsafe?
These questions are more than valid. And they provide an opportunity to explain clearly, rigorously, and honestly how we approach this topic at Banbu: based on scientific knowledge, but also on a genuine ethical commitment to health and the environment.
What does European legislation say about endocrine disruptors?
The European Union regulates cosmetic products through Regulation (EC) No 1223/2009, one of the most advanced regulations worldwide. It includes restrictions and prohibitions on substances that may pose a risk to human health, including endocrine disruptors, although there is not yet a closed and official list of substances prohibited exclusively because of their hormonal activity.
In Article 15, this regulation prohibits the use of substances classified as carcinogenic, mutagenic, or toxic to reproduction (CMR), except for exceptions that the Commission may authorize after an evaluation by the Scientific Committee on Consumer Safety (SCCS). Regarding EDCs, the approach is broader: substances are evaluated on a case-by-case basis, and prohibition only occurs when the risk has been scientifically confirmed and there are no viable alternatives.
In 2019, the European Commission published a priority list of 28 substances used in cosmetics with possible endocrine-disrupting properties, in two groups of 14, for the SCCS to evaluate. Being on the list does not mean being prohibited. Since then, the EU has already taken action on several: 4-MBC sunscreen is prohibited from 2025, and benzophenone-3, octocrylene, homosalate, BHT, genistein, daidzein, kojic acid, and triclocarban have usage limits. Others are still being evaluated.
In addition, since 2023, the European CLP substance classification regulation has included the “endocrine disruptor” category, which will be applied as substances are classified.
How to read the label in 5 steps
- Look for the list of ingredients (INCI) on the packaging or box; online, it should be on the product page. They are listed in order of decreasing concentration; those below 1% can be listed in any order.
- Look for the names in the table. The INCI uses English or Latin names: “Butylparaben,” “BHT,” “Benzophenone-3.”
- Check its status: prohibited, restricted, or under evaluation. A restricted ingredient used within its limit is legal.
- Look for “Parfum” or “Fragrance.” Perfume is declared with a single word; only allergens are declared separately. If you want to know more, ask the brand or choose products without added perfume.
- Consult the official source: the European Commission’s CosIng database indicates whether an ingredient is prohibited or restricted.
Table: identified ingredients and their status in the EU
Status as of November 2026. It includes substances from the European priority list found in cosmetics and others that are frequently mentioned.
| INCI name | What it is used for | Status in the EU |
|---|---|---|
| Isobutylparaben, Isopropylparaben, Phenylparaben, Benzylparaben, Pentylparaben | Preservatives | Prohibited (Regulation 358/2014) |
| Butylparaben, Propylparaben | Preservatives | Restricted: max. 0.14% between the two; prohibited in leave-on products for the diaper area of children under 3 years (Regulation 1004/2014). Butylparaben, under evaluation |
| Methylparaben, Ethylparaben | Preservatives | Restricted: max. 0.4% each and 0.8% in mixture. Methylparaben, under evaluation |
| 4-Methylbenzylidene Camphor (4-MBC) | Sunscreen | Prohibited: cannot be sold from May 1, 2026 (Regulation 2024/996) |
| Benzophenone-3 (Oxybenzone) | Sunscreen | Restricted: 6% on face, lips, and hands; 2.2% on body; 0.5% to protect the formula (Regulation 2022/1176) |
| Octocrylene | Sunscreen | Restricted: 10%, 9% in aerosols (Regulation 2022/1176) |
| Homosalate | Sunscreen | Restricted: 7.34%, only in face products and not in aerosols (Regulation 2022/2195) |
| Ethylhexyl Methoxycinnamate (Octinoxate) | Sunscreen | Allowed up to 10%; under evaluation |
| Benzophenone-1, Benzophenone-2, Benzophenone-4, Benzophenone-5 | Sunscreens and product protection from light | Under evaluation (2019 list) |
| BHT (Butylated Hydroxytoluene) | Antioxidant | Restricted: 0.001% in mouthwash, 0.1% in toothpaste, 0.8% in the rest (Regulation 2022/2195) |
| BHA (Butylated Hydroxyanisole) | Antioxidant | Under evaluation (2019 list) |
| Triclosan | Antibacterial | Restricted to certain products and concentrations (Annex V) |
| Triclocarban | Antibacterial | Restricted: max. 0.2% (Regulation 2024/996) |
| Genistein, Daidzein | Antioxidants (isoflavones) | Restricted: max. 0.007% and 0.02% (Regulation 2024/996) |
| Kojic Acid | Depigmenting | Restricted: max. 1%, only in face and hand products (Regulation 2024/996) |
| Cyclotetrasiloxane (D4) | Silicone | Cannot be used in cosmetics; only unavoidable traces are allowed |
| Cyclopentasiloxane (D5), Cyclohexasiloxane (D6) | Silicones | Max. 0.1% in rinse-off products; in all cosmetics from June 6, 2027 (REACH Regulation 2024/1328) |
| Dibutyl Phthalate (DBP), Diethylhexyl Phthalate (DEHP) | Plasticizers (fragrances, nail polishes) | Prohibited (Annex II) |
| Diethyl Phthalate (DEP) | Fragrance solvent | Allowed |
The fact that an ingredient appears in the table does not mean that a product containing it is dangerous: if it meets the limits, it is legal and safe according to the current evaluation.
What is Banbu's approach?
At Banbu, we are not satisfied with this priority list. We believe that waiting for ingredients that have already been scientifically questioned, even if they are still legal, to be officially prohibited is not consistent with our preventive, ethical, and responsible vision.
We apply a stricter criterion, based on five key principles:
1. Multi-source scientific review
We are guided by multiple references, not just current legislation:
- Updated SCCS opinions.
- Lists of substances considered candidates for “substances of very high concern” (SVHC) by the European Chemicals Agency (ECHA).
- Scientific statements from the Endocrine Society, a pioneer in EDC research.
- Evaluations by international organizations such as the WHO/UNEP (2013).
- Academic studies on combined exposure and low-dose effects (Vandenberg et al., 2012).
2. Application of the precautionary principle
If an ingredient is legal but presents credible evidence of hormonal risk, even if there is no definitive consensus, we choose to exclude it. We prefer to err on the side of caution rather than wait for an official ruling that could take years.
3. Avoid controversial ingredients, even if they are permitted
Our formulation team systematically avoids compounds such as:
- Butylparaben
- Benzophenone-3 (oxybenzone)
- BHA / BHT
- Cyclotetrasiloxane (D4) and other cyclic siloxanes
- Synthetic fragrances with phthalates or nitrated musks
Several of them are on the European priority list, and some already have limits in the EU: butylparaben cannot be used in leave-on products for the diaper area of children under 3 years, and benzophenone-3 has a maximum of 6% in face products. Others are limited for other reasons: D4 can no longer be used in cosmetics, and D5 and D6 will have a maximum of 0.1% in leave-on products from June 2027. In the table in this guide, you can find the status of each one.
4. Evaluation of the “cocktail effect”
Traditional toxicology evaluates substances one by one, but we know that endocrine disruptors can produce cumulative or synergistic effects even if each is present in legal concentrations. This phenomenon—the “cocktail effect”—has been documented by the European Commission itself as one of the main gaps in current regulation.
That is why we do not look at each ingredient in isolation: we apply the same exclusion criterion to the entire formula and ensure that each product contains only the necessary ingredients.
5. Thinking about those who are most concerned about these ingredients
Many of the people who ask us about endocrine disruptors are pregnant or trying to conceive, have young children, or are going through hormonal changes. That is why we apply this criterion to the entire range, including children's products. If you are pregnant or have a medical condition, consult your healthcare professional.
We work with raw materials approved or COSMOS certified by their suppliers, and we ask each supplier for the technical documentation of each ingredient.
Does this mean that European cosmetics are unsafe?
No. And this is very important.
The European Regulation is one of the safest in the world. We recognize its value and rigor. But we also know—and the Commission itself says it—that there are still many scientific unknowns regarding the effects of EDCs, especially in the long term and with multiple exposures.
That is why at Banbu we do not speak from fear, but from science. We do not intend to cause alarm or suggest that conventional cosmetics are “poison.” Our difference lies in applying a voluntarily stricter standard, based on available scientific evidence and a preventive criterion.
What we offer: transparency and evidence-based confidence
Our EDC exclusion policy is not a marketing strategy. It is a formulation decision that impacts the entire process:
- Selection of suppliers with detailed technical documentation.
- Replacement of questioned ingredients with alternatives that are not under evaluation.
- Each product has the safety assessment required by the European Regulation, signed by a qualified assessor.
- Clear communication, without false promises, but with ethical firmness.
Conclusion
We choose to go beyond the legal minimum not because the law is insufficient, but because we prefer to get ahead of evaluations that are still ongoing. And we share this transparently: you can consult the ingredients we do not use, the ingredient glossary, and the full INCI list on each product page.
Frequently asked questions
Is there an official list of endocrine disruptors in cosmetics?
There is no closed list. The 2019 list indicates which substances to evaluate first, not which ones are prohibited. Prohibited and restricted substances are in the annexes of Regulation (EC) 1223/2009, which you can consult on CosIng.
Is a cosmetic with an ingredient from the table dangerous?
Not necessarily. If it meets the legal limits, it is safe according to the current evaluation. The table is used to make informed choices, not to cause alarm.
What does “free from endocrine disruptors” mean on packaging?
There is no official European seal. Ask the brand what criterion it follows. At Banbu, we explain it in this guide and on the ingredients we do not use page.
Where can I see the ingredients of Banbu products?
On each product page, with the full INCI list.
To learn more
- Everything you need to know about endocrine disruptors
- Endocrine disruptors: 6 changes to reduce your exposure
- Nutrasalud: how to identify a cosmetic free from endocrine disruptors in five steps, with advice from Verónica Díez and Rodrigo Folgueira
Technical and scientific bibliography
- SCCS Opinions on Benzophenone-3, Butylparaben, Cyclotetrasiloxane, etc. (2021–2023)
- WHO/UNEP (2013). State of the Science of Endocrine Disrupting Chemicals
- Vandenberg LN et al. (2012). Endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine Reviews
- ECHA – Candidate List of Substances of Very High Concern for Authorization
- Endocrine Society (2009, 2015). Scientific Statements on Endocrine Disruption
- Regulation (EU) 2022/1176, Regulation (EU) 2022/2195, Regulation (EU) 2024/996, and Regulation (EU) 2024/1328